Novel Calculator Guides Treatment Choice in Esophageal Cancer

A novel calculator can more easily identify which esophageal adenocarcinoma patients derive an overall survival benefit from neoadjuvant chemoradiation to help guide treatment choices.

Source: CancerNetwork - March 23, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Esophageal Cancer Gastrointestinal Cancer News Source Type: news